Table 2.
Variable | B | SE | β | 95% CI for B | R2 | P |
---|---|---|---|---|---|---|
| ||||||
Fmax_hFE | ||||||
Intercept | 0.938 | 0.72 | −0.292 – 2.169 | |||
F_hFE (kN) | 0.781 | 0.078 | 0.641 – 0.919 | 0.78 | <0.001 | |
Clinical classification with Fmax_hFE | ||||||
Intercept | 1.205 | 0.72 | −0.273 – 2.68 | |||
| ||||||
F_hFE | 0.779 | 0.078 | 0.883 | 0.620 – 0.937 | 0.77 | <.0001 |
Lesion classification | ||||||
Blastic | −0.487 | 0.396 | 0.098 | −1.293 – 0.319 | 0.228 | |
Mixed | −0.094 | 0.479 | 0.016 | −0.879 – 0.806 | 0.947 | |
Lytic | −0.241 | 0.512 | 0.041 | −1.283 – 0.319 | 0.641 | |
K_μFE | ||||||
Intercept | 2.945 | 1.723 – 4.166 | ||||
K_μFE (kN/mm) | 0.08 | 0.010 | 0.063 – 0.104 | 0.66 | <.0001 | |
Clinical classification with K_μFE | ||||||
Intercept | 3.540 | 0.580 | 2.359 – 4.727 | <.0001 | ||
K_μFE | 0.082 | 0.009 | 0.797 | 0.063 – 0.100 | 0.73 | <.0001 |
Lesion classification | 0.76 | 0.0146 | ||||
Blastic | −0.225 | 0.426 | −0.045 | −1.093 – 0.643 | 0.602 | |
Mixed | −1.158 | 0.487 | −0.111 | −1.759 – 0.412 | 0.2158 | |
Lytic | −1.667 | 0.533 | −0.286 | −2.702 – 0.633 | 0.0025 | |
BMC with K_μFE | ||||||
Intercept | 0.531 | −0.539 – 1.618 | ||||
K_μFE | 0.0542 | 0.008 | 0.527 | 0.0382 – 0.0702 | <.0001 | |
BMC | 0.5395 | 0.0002 | 0.5257 | 0.0008 – 0.0014 | <.0001 |